Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

DynamX Bioadaptor coronary stent shows promise in pilot study

Key clinical point: A new concept in coronary stent design shows early promise.

Major finding: There were no cases of target lesion revascularization, device thrombosis, or strut fracture within 12 months after implantation of the DynamX Bioadaptor coronary stent in a small pilot study.

Study details: This was an uncontrolled study of the performance of a novel coronary stent in 50 patients followed for 1 year.

Disclosures: The presenter reported serving as a consultant to Elixir Medical, the study sponsor.


Verheye S. EuroPCR 2020.